Association of Dyslipidemia in Decreased Glomerular Filtration Rate in Patients with CKD KDIGO ≥ 3

Zayra Carolina, Rojas Castillo, Elizabeth Ruíz López, Moisés Moreno Noguez, Eleane Daniela Solorio Adame, Blanca Estela, Herrera Morales, Luis Rey, García Cortés, Olga Lidia, Toxqui Delgado, Victor Itai, Urbalejo Ceniceros, Dana Aline Pérez Camargo, Victor Manuel Enriquez Estrada, María Rebeca Velasco Domínguez
{"title":"Association of Dyslipidemia in Decreased Glomerular Filtration Rate in Patients with CKD KDIGO ≥ 3","authors":"Zayra Carolina, Rojas Castillo, Elizabeth Ruíz López, Moisés Moreno Noguez, Eleane Daniela Solorio Adame, Blanca Estela, Herrera Morales, Luis Rey, García Cortés, Olga Lidia, Toxqui Delgado, Victor Itai, Urbalejo Ceniceros, Dana Aline Pérez Camargo, Victor Manuel Enriquez Estrada, María Rebeca Velasco Domínguez","doi":"10.29011/2574-7754.101740","DOIUrl":null,"url":null,"abstract":"Objective. To determine the association of dyslipidemia with decreased glomerular filtration rate (eGFR) in patients with CKD KDIGO ≥3. Material and methods. Observational, analytical, longitudinal, ambispective study; was carried out at the Family Medicine Unit (UMF) No. 55 Zumpango, the sample size was calculated using the mean difference formula, with an expected mean of 5.2, obtaining n= 90 patients with CKD KDIGO ≥3 , between 20-69 years. Patients with dyslipidemia and without dyslipidemia were classified into 2 groups, in which creatinine was evaluated to calculate the estimated glomerular filtration rate (eGFR), total cholesterol and triglycerides, subjects with renal function replacement therapy, patients with pathologies or treatments that modify lipid metabolism. For the bivariate analysis, the Student’s T test and the Mann-Whitney U test were applied according to the type of distribution presented by the eGFR values for the groups with and without dyslipidemia. Result and conclusion. Based on the eGFR values for the groups with and without dyslipidemia, they show that patients aged 20 to 69 years with CKD KDIGO ≥ 3 with dyslipidemia presented a mean eGFR of 40.24 for the first analysis, and 34.70 for the follow-up analysis., with a mean difference of 5.53, which was significant (p=0.003).","PeriodicalId":72213,"journal":{"name":"Annals of case reports","volume":"185 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2574-7754.101740","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective. To determine the association of dyslipidemia with decreased glomerular filtration rate (eGFR) in patients with CKD KDIGO ≥3. Material and methods. Observational, analytical, longitudinal, ambispective study; was carried out at the Family Medicine Unit (UMF) No. 55 Zumpango, the sample size was calculated using the mean difference formula, with an expected mean of 5.2, obtaining n= 90 patients with CKD KDIGO ≥3 , between 20-69 years. Patients with dyslipidemia and without dyslipidemia were classified into 2 groups, in which creatinine was evaluated to calculate the estimated glomerular filtration rate (eGFR), total cholesterol and triglycerides, subjects with renal function replacement therapy, patients with pathologies or treatments that modify lipid metabolism. For the bivariate analysis, the Student’s T test and the Mann-Whitney U test were applied according to the type of distribution presented by the eGFR values for the groups with and without dyslipidemia. Result and conclusion. Based on the eGFR values for the groups with and without dyslipidemia, they show that patients aged 20 to 69 years with CKD KDIGO ≥ 3 with dyslipidemia presented a mean eGFR of 40.24 for the first analysis, and 34.70 for the follow-up analysis., with a mean difference of 5.53, which was significant (p=0.003).
血脂异常与慢性肾功能衰竭 KDIGO ≥ 3 患者肾小球滤过率降低的关系
目的确定血脂异常与 CKD KDIGO≥3 患者肾小球滤过率(eGFR)下降的关系。材料和方法。观察性、分析性、纵向、前瞻性研究;在 Zumpango 第 55 号家庭医学科(UMF)进行,样本量使用平均差公式计算,预期平均值为 5.2,共获得 90 名 20-69 岁的 CKD KDIGO ≥3 患者。将有血脂异常和无血脂异常的患者分为两组,其中评估肌酐以计算估计肾小球滤过率(eGFR)、总胆固醇和甘油三酯、接受肾功能替代治疗的受试者、有改变脂质代谢的病变或治疗的患者。在双变量分析中,根据血脂异常组和非血脂异常组 eGFR 值的分布类型,采用了学生 T 检验和曼-惠特尼 U 检验。结果和结论。根据血脂异常组和无血脂异常组的 eGFR 值显示,20 至 69 岁的 CKD KDIGO≥3 且伴有血脂异常的患者,首次分析的平均 eGFR 值为 40.24,随访分析的平均 eGFR 值为 34.70,平均差为 5.53,差异显著(P=0.003)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信